ALTEOGEN Inc. (196170.KQ)
KRW 286500.0
(-3.54%)
KRW 286500.0
(-3.54%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 256.09 Billion KRW | 4.32% |
| 2022 | 245.49 Billion KRW | -4.97% |
| 2021 | 258.31 Billion KRW | 62.25% |
| 2020 | 159.2 Billion KRW | 85.17% |
| 2019 | 85.97 Billion KRW | 20.45% |
| 2018 | 71.38 Billion KRW | 65.95% |
| 2017 | 43.01 Billion KRW | -10.29% |
| 2016 | 47.94 Billion KRW | 21.74% |
| 2015 | 39.38 Billion KRW | 3.76% |
| 2014 | 37.95 Billion KRW | 356.34% |
| 2013 | 8.31 Billion KRW | 45.45% |
| 2012 | 5.71 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 306.27 Billion KRW | 11.53% |
| 2024 Q1 | 274.62 Billion KRW | 7.23% |
| 2023 FY | 256.09 Billion KRW | 4.32% |
| 2023 Q4 | 256.09 Billion KRW | -4.23% |
| 2023 Q1 | 251.17 Billion KRW | 2.32% |
| 2023 Q3 | 267.41 Billion KRW | -1.21% |
| 2023 Q2 | 270.7 Billion KRW | 7.77% |
| 2022 Q4 | 245.49 Billion KRW | -1.73% |
| 2022 Q2 | 259.1 Billion KRW | -0.12% |
| 2022 FY | 245.49 Billion KRW | -4.97% |
| 2022 Q1 | 259.42 Billion KRW | -0.35% |
| 2022 Q3 | 249.81 Billion KRW | -3.59% |
| 2021 Q4 | 260.33 Billion KRW | 2.87% |
| 2021 FY | 258.31 Billion KRW | 62.25% |
| 2021 Q2 | 258.51 Billion KRW | -1.82% |
| 2021 Q3 | 253.07 Billion KRW | -2.11% |
| 2021 Q1 | 263.32 Billion KRW | 65.4% |
| 2020 Q4 | 159.2 Billion KRW | 55.67% |
| 2020 Q3 | 102.27 Billion KRW | 4.21% |
| 2020 Q1 | 92.45 Billion KRW | 7.53% |
| 2020 Q2 | 98.14 Billion KRW | 6.15% |
| 2020 FY | 159.2 Billion KRW | 85.17% |
| 2019 Q2 | 72.83 Billion KRW | 1.38% |
| 2019 Q3 | 73.1 Billion KRW | 0.38% |
| 2019 FY | 85.97 Billion KRW | 20.45% |
| 2019 Q1 | 71.83 Billion KRW | 0.64% |
| 2019 Q4 | 85.97 Billion KRW | 17.61% |
| 2018 Q1 | 41.88 Billion KRW | -2.62% |
| 2018 Q4 | 71.38 Billion KRW | -2.7% |
| 2018 FY | 71.38 Billion KRW | 65.95% |
| 2018 Q2 | 73.05 Billion KRW | 74.4% |
| 2018 Q3 | 73.35 Billion KRW | 0.42% |
| 2017 Q1 | 47.62 Billion KRW | -0.68% |
| 2017 FY | 43.01 Billion KRW | -10.29% |
| 2017 Q3 | 45.15 Billion KRW | -1.44% |
| 2017 Q2 | 45.8 Billion KRW | -3.81% |
| 2017 Q4 | 43.01 Billion KRW | -4.73% |
| 2016 Q2 | 39.73 Billion KRW | 2.03% |
| 2016 Q3 | 48.48 Billion KRW | 22.03% |
| 2016 Q4 | 47.94 Billion KRW | -1.1% |
| 2016 FY | 47.94 Billion KRW | 21.74% |
| 2016 Q1 | 38.94 Billion KRW | -1.12% |
| 2015 FY | 39.38 Billion KRW | 3.76% |
| 2015 Q2 | 37.97 Billion KRW | -1.43% |
| 2015 Q1 | 38.52 Billion KRW | 1.49% |
| 2015 Q3 | 38.22 Billion KRW | 0.66% |
| 2015 Q4 | 39.38 Billion KRW | 3.03% |
| 2014 Q4 | 37.95 Billion KRW | 0.0% |
| 2014 FY | 37.95 Billion KRW | 356.34% |
| 2014 Q2 | 15.06 Billion KRW | 0.0% |
| 2014 Q1 | - KRW | -100.0% |
| 2013 Q3 | 8.31 Billion KRW | 0.0% |
| 2013 Q1 | - KRW | 0.0% |
| 2013 Q4 | 8.31 Billion KRW | 0.0% |
| 2013 FY | 8.31 Billion KRW | 45.45% |
| 2012 FY | 5.71 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| HLB Co., Ltd. | 751.72 Billion KRW | 65.932% |
| iNtRON Biotechnology, Inc. | 98.61 Billion KRW | -159.698% |
| BINEX Co., Ltd. | 257.01 Billion KRW | 0.355% |
| Bioneer Corporation | 315.48 Billion KRW | 18.824% |
| Anterogen.Co.,Ltd. | 149.43 Billion KRW | -71.383% |
| MEDIPOST Co., Ltd. | 449.39 Billion KRW | 43.012% |
| CrystalGenomics, Inc. | 243.11 Billion USD | -5.341% |
| Helixmith Co., Ltd | 227.27 Billion KRW | -12.681% |
| Chabiotech Co.,Ltd. | 1725.57 Billion KRW | 85.159% |
| Medy-Tox Inc. | 611.62 Billion KRW | 58.128% |
| Peptron, Inc. | 52.49 Billion KRW | -387.847% |
| Amicogen, Inc. | 467.09 Billion KRW | 45.172% |
| Genexine, Inc. | 376.58 Billion KRW | 31.994% |
| HLB Therapeutics Co.,Ltd. | 200.79 Billion KRW | -27.543% |
| LegoChem Biosciences, Inc. | 189.5 Billion KRW | -35.144% |
| PharmaResearch Co., Ltd. | 535.28 Billion KRW | 52.156% |
| SillaJen, Inc. | 76.71 Billion KRW | -233.833% |
| JETEMA, Co., Ltd. | 252.14 Billion KRW | -1.568% |
| OliX Pharmaceuticals,Inc | 102.82 Billion KRW | -149.064% |
| Genomictree Inc. | 132.84 Billion KRW | -92.782% |
| MedPacto, Inc. | 80.47 Billion KRW | -218.238% |
| D&D Pharmatech | 79.2 Billion KRW | -223.344% |
| EASY BIO,Inc. | 172.04 Billion KRW | -48.859% |
| GI Innovation, Inc. | 81.34 Billion KRW | -214.85% |